Clinical trial
Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium…
NCT00004689 · National Jewish Health, Other · Completed
Key facts
| NCT number | NCT00004689 |
|---|---|
| Title | Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease |
| Lead sponsor | National Jewish Health, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mycobacterium Avium-intracellulare Infection |
| Intervention type | Drug |
| Interventions | amithiozone, clarithromycin, ethambutol, rifampin, streptomycin |
| Enrollment | 50 |
| Start date | Jan 1, 1991 |
| Completion | Sep 1, 1998 |
| First posted | Feb 25, 2000 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: